{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T22:10:08Z","timestamp":1747087808908,"version":"3.40.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,12]]},"DOI":"10.7759\/cureus.83978","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T21:30:12Z","timestamp":1747085412000},"source":"Crossref","is-referenced-by-count":0,"title":["A Rare Case of Chronic Myelomonocytic Leukemia in a Patient With Sarcoidosis: Diagnostic and Immunologic Challenges"],"prefix":"10.7759","author":[{"given":"Ani","family":"Toloraia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitri","family":"Daraselia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ninaka","family":"Gvamberia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marika","family":"Todua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Chronic myelomonocytic leukemia (CMML). (2025). Accessed. May 12, 2025: https:\/\/www.mll.com\/en\/myelodysplastic-myeloproliferative-neoplasm-mds-mpn\/chronic-myelomonocytic-leukemia-cmml."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01443","article-title":"Biomarkers in the diagnosis and prognosis of sarcoidosis: current use and future prospects","volume":"11","author":"Kraaijvanger R","year":"2020","unstructured":"Kraaijvanger R, Janssen Bon\u00e1s M, Vorselaars AD, Veltkamp M. Biomarkers in the diagnosis and prognosis of sarcoidosis: current use and future prospects. Front Immunol. 2020, 11:1443. 10.3389\/fimmu.2020.01443","journal-title":"Front Immunol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1378\/chest.124.1.186","article-title":"Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation","volume":"124","author":"Grutters JC","year":"2003","unstructured":"Grutters JC, Fellrath JM, Mulder L, Janssen R, van den Bosch JM, van Velzen-Blad H. Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation. Chest. 2003, 124:186-95. 10.1378\/chest.124.1.186","journal-title":"Chest"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3109\/10428199709058343","article-title":"Plasma soluble interleukin-2 receptors in patients with myelodysplastic syndromes","volume":"28","author":"Yokose N","year":"1997","unstructured":"Yokose N, Ogata K. Plasma soluble interleukin-2 receptors in patients with myelodysplastic syndromes. Leuk Lymphoma. 1997, 28:171-6. 10.3109\/10428199709058343","journal-title":"Leuk Lymphoma"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000206923","article-title":"Serum beta-2-microglobulin in disorders of myeloid proliferation","volume":"69","author":"Norfolk DR","year":"1983","unstructured":"Norfolk DR, Child JA, Roberts BE, Forbes MA, Cooper EH. Serum beta-2-microglobulin in disorders of myeloid proliferation. Acta Haematol. 1983, 69:361-8. 10.1159\/000206923","journal-title":"Acta Haematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13237045","article-title":"The association between sarcoidosis and malignancy: a comprehensive population-based cohort study","volume":"13","author":"Patt YS","year":"2024","unstructured":"Patt YS, Ben-Shabat N, Sharif K, et al.. The association between sarcoidosis and malignancy: a comprehensive population-based cohort study. J Clin Med. 2024, 13:7045. 10.3390\/jcm13237045","journal-title":"J Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26020594","article-title":"Pathogenetic mechanisms linking sarcoidosis to lymphoma","volume":"26","author":"Voutidou S","year":"2025","unstructured":"Voutidou S, Eleftheriadis D, Drakopanagiotakis F, Papanikolaou IC, Steiropoulos P. Pathogenetic mechanisms linking sarcoidosis to lymphoma. Int J Mol Sci. 2025, 26:594. 10.3390\/ijms26020594","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1159\/000066420","article-title":"Sarcoidosis preceding chronic myelomonocytic leukemia. Report of two cases","volume":"205","author":"Serratrice J","year":"2002","unstructured":"Serratrice J, Granel B, Swiader L, et al.. Sarcoidosis preceding chronic myelomonocytic leukemia. Report of two cases. Dermatology. 2002, 205:409-12. 10.1159\/000066420","journal-title":"Dermatology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.788502","article-title":"The role of diverse immune cells in sarcoidosis","volume":"12","author":"Zhang H","year":"2021","unstructured":"Zhang H, Costabel U, Dai H. The role of diverse immune cells in sarcoidosis. Front Immunol. 2021, 12:788502. 10.3389\/fimmu.2021.788502","journal-title":"Front Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25684","article-title":"Chronic myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management","volume":"95","author":"Patnaik MM","year":"2020","unstructured":"Patnaik MM, Tefferi A. Chronic myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management. Am J Hematol. 2020, 95:97-115. 10.1002\/ajh.25684","journal-title":"Am J Hematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00804-2020","article-title":"Distinct immune regulatory receptor profiles linked to altered monocyte subsets in sarcoidosis","volume":"7","author":"Fraser SD","year":"2021","unstructured":"Fraser SD, Crooks MG, Kaye PM, Hart SP. Distinct immune regulatory receptor profiles linked to altered monocyte subsets in sarcoidosis. ERJ Open Res. 2021, 7:00804-2020. 10.1183\/23120541.00804-2020","journal-title":"ERJ Open Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02511-4","article-title":"Multi-omic analysis of chronic myelomonocytic leukemia monocytes reveals metabolic and immune dysregulation leading to altered macrophage polarization","volume":"39","author":"Addinsell HM","year":"2025","unstructured":"Addinsell HM, Cant R, Hull NJ, Wang YH, Somervaille TC, Wiseman DH, Batta K. Multi-omic analysis of chronic myelomonocytic leukemia monocytes reveals metabolic and immune dysregulation leading to altered macrophage polarization. Leukemia. 2025, 39:770-4. 10.1038\/s41375-024-02511-4","journal-title":"Leukemia"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.137","article-title":"High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial","volume":"28","author":"Rossille D","year":"2014","unstructured":"Rossille D, Gressier M, Damotte D, et al.. High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial. Leukemia. 2014, 28:2367-75. 10.1038\/leu.2014.137","journal-title":"Leukemia"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-06-440347","article-title":"Clonal architecture of chronic myelomonocytic leukemias","volume":"121","author":"Itzykson R","year":"2013","unstructured":"Itzykson R, Kosmider O, Renneville A, et al.. Clonal architecture of chronic myelomonocytic leukemias. Blood. 2013, 121:2186-98. 10.1182\/blood-2012-06-440347","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2022.12.001","article-title":"Clonal hematopoiesis and inflammation - the perpetual cycle","volume":"33","author":"Avagyan S","year":"2023","unstructured":"Avagyan S, Zon LI. Clonal hematopoiesis and inflammation - the perpetual cycle. Trends Cell Biol. 2023, 33:695-707. 10.1016\/j.tcb.2022.12.001","journal-title":"Trends Cell Biol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26455","article-title":"Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Patnaik MM","year":"2022","unstructured":"Patnaik MM, Tefferi A. Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and management. Am J Hematol. 2022, 97:352-72. 10.1002\/ajh.26455","journal-title":"Am J Hematol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2016.1143938","article-title":"Chronic inflammation and autoimmunity as risk factors for the development of chronic myelomonocytic leukemia?","volume":"57","author":"Elb\u00e6k MV","year":"2016","unstructured":"Elb\u00e6k MV, S\u00f8rensen AL, Hasselbalch HC. Chronic inflammation and autoimmunity as risk factors for the development of chronic myelomonocytic leukemia?. Leuk Lymphoma. 2016, 57:1793-9. 10.3109\/10428194.2016.1143938","journal-title":"Leuk Lymphoma"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-06-780882","article-title":"Inflammation: a key regulator of hematopoietic stem cell fate in health and disease","volume":"130","author":"Pietras EM","year":"2017","unstructured":"Pietras EM. Inflammation: a key regulator of hematopoietic stem cell fate in health and disease. Blood. 2017, 130:1693-8. 10.1182\/blood-2017-06-780882","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702874","article-title":"Resolution of sarcoidosis after allogeneic bone marrow transplantation with donor lymphocyte infusions","volume":"27","author":"Tauro S","year":"2001","unstructured":"Tauro S, Mahendra P. Resolution of sarcoidosis after allogeneic bone marrow transplantation with donor lymphocyte infusions. Bone Marrow Transplant. 2001, 27:757-9. 10.1038\/sj.bmt.1702874","journal-title":"Bone Marrow Transplant"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.06.060","article-title":"A case of aleukemic leukemia cutis mistaken for sarcoidosis","volume":"87","author":"Rodr\u00edguez-Rivera DV","year":"2022","unstructured":"Rodr\u00edguez-Rivera DV, Cuesta-Camunas J, Ramos-Rodriguez AJ. A case of aleukemic leukemia cutis mistaken for sarcoidosis. J Am Acad Dermatol. 2022, 87:7. 10.1016\/j.jaad.2022.06.060","journal-title":"J Am Acad Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/363775-a-rare-case-of-chronic-myelomonocytic-leukemia-in-a-patient-with-sarcoidosis-diagnostic-and-immunologic-challenges","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T21:30:13Z","timestamp":1747085413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/363775-a-rare-case-of-chronic-myelomonocytic-leukemia-in-a-patient-with-sarcoidosis-diagnostic-and-immunologic-challenges"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.83978","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,12]]}}}